凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06821 凯莱英

未开盘 05-21 16:08:15

99.000

+6.600

+7.14%

最高103.000	最低93.800	成交量86.81万
今开93.800	昨收92.400	日振幅9.96%
总市值357.39亿	流通市值27.28亿	总股本3.61亿
成交额8,583万	换手率3.15%	流通股本2,755万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":99,"timestamp":1779350895007,"preClose":92.4,"halted":0,"volume":868080,"delay":0,"changeRate":0.07142857142857137,"floatShares":27553260,"shares":361000000,"eps":3.6409110068239334,"marketStatus":"未开盘","change":6.6,"latestTime":"05-21 16:08:15","open":93.8,"high":103,"low":93.8,"amount":85834118,"amplitude":0.099567,"askPrice":99.05,"askSize":5200,"bidPrice":99,"bidSize":4400,"shortable":3,"etf":0,"ttmEps":3.5809742376546354,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779413400000},"marketStatusCode":0,"adr":0,"listingDate":1639065600000,"exchange":"SEHK","adjPreClose":92.4,"dividendRate":0.012133,"openAndCloseTimeList":[[1779327000000,1779336000000],[1779339600000,1779350400000]],"volumeRatio":2.438911,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":126.15,"timestamp":1779346800000,"preClose":118.86,"halted":0,"volume":12364100,"delay":0,"premium":"-31.89"}},"requestUrl":"/m/hq/s/06821","defaultTab":"news","newsList":[{"id":"2637584807","title":"港股异动 | 凯莱英(06821)涨超7% 新兴业务表现强劲 机构看好其长期高增长确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2637584807","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637584807?lang=zh_cn&edition=full","pubTime":"2026-05-21 14:51","pubTimestamp":1779346283,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，凯莱英涨超7%，截至发稿，涨7.85%，报99.65港元，成交额7212万港元。消息面上， 凯莱英一季度业绩显示，营业收入18.02亿元，同比增16.91%；经调整归母净利润4.23亿元，同比增27.91%。分业务来看，一季度小分子CDMO 业务收入12亿元，同比增长 0.43%，恒定汇率下增长 3.26%；新兴业务收入5.98亿元，同比增长74.07%，主要是化学大分子和生物大分子业务板块增长强劲。公司在高景气度赛道的后期订单规模扩大和前瞻性投入，可望带来较强的长期高增长确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444417.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","VXUS","002821","BK1191","LU1328615791.USD","BK0132","06821","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635203891","title":"凯莱英（002821）披露召开2025年度股东会及系列类别股东会通知，5月15日股价下跌3.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635203891","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635203891?lang=zh_cn&edition=full","pubTime":"2026-05-15 22:04","pubTimestamp":1778853891,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，凯莱英报收于117.97元，较前一交易日下跌3.45%，最新总市值为425.72亿元。该股当日开盘122.41元，最高125.31元，最低116.92元，成交额达10.31亿元，换手率为2.7%。近日，凯莱英医药集团（天津）股份有限公司发布《关于召开2025年度股东会、2026年第二次A股类别股东会及2026年第二次H股类别股东会的通知》。股权登记日为2026年6月2日，A股股东可通过深圳证券交易所系统或互联网投票系统参与网络投票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500043789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","BK0132","LU1328615791.USD","002821","BK0239","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181849212","title":"凯莱英更新末期股息派息安排，每10股派13元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1181849212","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181849212?lang=zh_cn&edition=full","pubTime":"2026-05-15 20:21","pubTimestamp":1778847710,"startTime":"0","endTime":"0","summary":"凯莱英医药集团发布关于截至2025年12月31日止年度末期股息的更新公告，就香港过户登记处信息及代扣所得税安排作出补充。公司已宣派普通末期股息，基准为每10股派发现金红利13元人民币。由于预设派发货币为港元，最终每股港元派息金额及汇率有待公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"凯莱英更新末期股息派息安排，每10股派13元人民币","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635084117","title":"凯莱英(06821)将于7月24日派发末期股息每10股13元","url":"https://stock-news.laohu8.com/highlight/detail?id=2635084117","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635084117?lang=zh_cn&edition=full","pubTime":"2026-05-15 20:20","pubTimestamp":1778847630,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，该公司将于2026年7月24日派发截至2025年12月31日止年度的末期股息每10股13元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442453.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","LU1328615791.USD","002821","06821","BK0132","BK0239","BK4585","VIG","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193309403","title":"凯莱英拟于股东周年大会审议2025年度利润分配方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1193309403","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193309403?lang=zh_cn&edition=full","pubTime":"2026-05-15 20:01","pubTimestamp":1778846485,"startTime":"0","endTime":"0","summary":"凯莱英发布2025年股东周年大会通告，将于2026年6月10日举行股东周年大会，审议包括2025年度利润分配方案在内的多项议案。该方案仍为董事会建议，须经股东大会批准后方可实施。股东如有意出席大会，H股股东须于2026年6月4日下午四时三十分前完成股份过户登记。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"凯莱英拟于股东周年大会审议2025年度利润分配方案","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178542171","title":"花旗集团于凯莱英H股持股比例自5.91%降至5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178542171","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178542171?lang=zh_cn&edition=full","pubTime":"2026-05-13 18:07","pubTimestamp":1778666870,"startTime":"0","endTime":"0","summary":"根据香港交易所披露的最新权益变动信息，花旗集团在凯莱英H股的持股比例出现下降。具体数据显示，截至5月7日，花旗集团所持好仓头寸占该股已发行H股的比例已从此前的5.91%降至5.36%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU1328615791.USD","BK0132","002821","06821","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634740914","title":"5月11日凯莱英涨5.26%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634740914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634740914?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:36","pubTimestamp":1778488569,"startTime":"0","endTime":"0","summary":"证券之星消息，5月11日凯莱英涨5.26%，收盘报130.08元，换手率3.46%，成交量10.96万手，成交额13.92亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共67家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值1.742，较上一交易日下跌2.72%，近一年上涨10.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100022129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","159760","BK0239","BK1191","002821","LU1328615791.USD","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634409976","title":"凯莱英涨5.26%，开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2634409976","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634409976?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:35","pubTimestamp":1778488559,"startTime":"0","endTime":"0","summary":"今日凯莱英涨5.26%，收盘报130.08元。2026年4月1日，开源证券研究员余汝意发布了对凯莱英的研报《公司信息更新报告：收入利润高质增长，多赛道景气共振下迈向加速周期》，该研报对凯莱英给出“买入”评级。研报中预计2026-2028年公司归母净利润为15.07/18.59/23.12亿元，EPS为4.18/5.15/6.41元，当前股价对应PE为24.1/19.5/15.7倍，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中国银河的宋丽莹、程培。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100022123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","002821","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633687104","title":"【券商聚焦】中国银河：医药行业进入复苏周期 CXO板块景气度较高","url":"https://stock-news.laohu8.com/highlight/detail?id=2633687104","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633687104?lang=zh_cn&edition=full","pubTime":"2026-05-08 09:00","pubTimestamp":1778202049,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中国银河证券表示，2025年医药行业上市公司营业收入增长0.4%，归母净利润增长3.9%，扣非净利润下降4.1%，2026年一季度营业收入增长1.1%，归母净利润下降3.2%，扣非净利润增长2.0%。2025全年医药行业收入端小幅微增，主要系医保控费趋严，仿制药、耗材等集采常态化开展导致行业承压。2026年一季度创新药产业链高景气度延续，收入增幅扩大、非经常性损益占比下降，行业整体经营盈利能力提升，进入复苏上行周期。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1980878","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","06881","BK1161","BK1585","HK0000165453.HKD","LU0348767384.USD","LU2328871848.SGD","LU2476274720.SGD","03933","LU0417516902.SGD","LU2778985437.USD","02367","BK1583","LU0348766576.USD","02228","BK1593","BK1141","CXO","LU0640798160.USD","LU1719994722.HKD","BK1500","BK1588","02196","LU0348783233.USD","LU0561508036.HKD","06821","LU1303224171.USD","LU0307460666.USD","BK0276","01789","LU1251922891.USD","LU1794554557.SGD","02268","01530","BK1207","IE00BPRC5H50.USD","LU1961090484.USD","09688","LU0348735423.USD","06160","01099","LU0417516571.SGD","LU0417516738.SGD","LU0634319403.HKD","BK1197","09926","BK0188","601881","LU2488822045.USD","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633131181","title":"凯莱英（002821）披露H股证券变动月报表，5月6日股价下跌0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633131181","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633131181?lang=zh_cn&edition=full","pubTime":"2026-05-06 22:14","pubTimestamp":1778076864,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，凯莱英报收于124.68元，较前一交易日下跌0.7%，最新总市值为449.94亿元。该股当日开盘123.2元，最高125.48元，最低120.8元，成交额达10.32亿元，换手率为2.63%。近日，凯莱英医药集团（天津）股份有限公司披露《证券变动月报表》。公告显示，截至2026年4月30日，公司H股总数为27,834,510股，全部已发行并上市；A股总数为333,040,460股，其中已发行331,889,160股，库存股1,151,300股。公司确认H股类别已满足联交所规定的公众持股量要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600039681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","BK0132","161027","LU1328615791.USD","BK1191","BK0239","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171759065","title":"凯莱英更新4月股份变动月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1171759065","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171759065?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:57","pubTimestamp":1778057857,"startTime":"0","endTime":"0","summary":"凯莱英医药集团（天津）股份有限公司于2026年5月6日发布4月证券变动月报表。报告期为截至2026年4月30日止一个月。H股已发行股数为27,834,510股，面值人民币1元/股，对应已发行股本人民币27,834,510元，当月无增加或减少；上述合计数显示，公司本月底已发行股本总额为人民币360,874,970元，较上月无变动。公司表示，截至2026年4月30日，已满足联交所对公众持股量的相关要求，本期股本结构维持稳定。公告由公司联席公司秘书徐向科签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633900974","title":"凯莱英：公司持续提升连续性反应以及各项新技术的应用率","url":"https://stock-news.laohu8.com/highlight/detail?id=2633900974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633900974?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:45","pubTimestamp":1778057123,"startTime":"0","endTime":"0","summary":"证券之星消息，凯莱英05月06日在投资者关系平台上答复投资者关心的问题。基于公平公正的信息披露原则和CDMO行业准则以及商业秘密保护的义务，公司不便回复未曾披露的订单对应主要成分\\主要结构等详细信息。公司持续提升连续性反应以及各项新技术的应用率，在研发投入也保持行业领先。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600025210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","LU1328615791.USD","BK0132","002821","BK1191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160542788","title":"花旗集团在凯莱英H股长仓比重降至7.11% 较4月28日9.86%显著收缩","url":"https://stock-news.laohu8.com/highlight/detail?id=1160542788","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160542788?lang=zh_cn&edition=full","pubTime":"2026-05-05 17:32","pubTimestamp":1777973540,"startTime":"0","endTime":"0","summary":"香港交易所最新披露数据显示，花旗集团对凯莱英（Asymchem Laboratories）H股的持股权比例出现明显调整。截至4月28日，其长仓持仓比例从先前公布的9.86%下降至7.11%，减持幅度达2.75个百分点。\n此次持股变动引发市场关注，机构投资者对医药外包服务板块的配置策略可能正在发生微妙变化。作为全球领先的医药研发生产服务商，凯莱英的H股流动性向来备受国际资本青睐。花旗集团此次仓位调整是否预示其对CXO行业前景的重新评估，值得进一步观察。\n二级市场数据显示，近期生物医药板块整体面临估值回调压力，机构持仓结构的变化往往成为行业风向标。投资者需密切关注后续可能出现的连锁反应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK0239","002821","06821","BK0132","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157054122","title":"摩根大通持仓凯莱英H股比例降至7.64% 较上月减持0.54个百分点","url":"https://stock-news.laohu8.com/highlight/detail?id=1157054122","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157054122?lang=zh_cn&edition=full","pubTime":"2026-05-04 17:27","pubTimestamp":1777886836,"startTime":"0","endTime":"0","summary":"根据香港交易所最新披露文件显示，国际投行摩根大通对凯莱英医药集团H股的持股比例出现调整。截至4月28日，其长期持仓比例已从先前公布的8.18%降至7.64%，减持幅度达0.54个百分点。\n此次持股变动引发市场对机构投资者策略的关注。作为全球领先的医药研发生产服务商，凯莱英近年来持续获得资本市场的青睐。摩根大通此次持仓调整或反映其对该股估值水平的重新评估，亦可能基于投资组合再平衡的常规操作。\n值得关注的是，此次披露的持股比例变化仅涉及H股部分。根据公开信息，凯莱英同时在内地A股市场上市，两地股价走势及机构持仓策略往往存在联动效应。投资者需综合考量企业基本面、行业政策环境及市场流动性等多重因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","002821","06821","BK0132","BK0239","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632604150","title":"格隆汇个股放量排行榜 | 5月3日","url":"https://stock-news.laohu8.com/highlight/detail?id=2632604150","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632604150?lang=zh_cn&edition=full","pubTime":"2026-05-03 17:30","pubTimestamp":1777800604,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日天数智芯(09903)、上海实业控股(00363)、网易-S(09999)、永达汽车(03669)、永利澳门(01128)、中国铁建(01186)、中国信达(01359)、力量发展(01277)、中国光大银行(06818)、汽车街(02443)、中国白银集团(00815)、赛力斯(09927)、太古股份公司A(00019)、中信国际电讯(01883)、华星控股(08","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/03173056983654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["00178","00981","00659","02516","02443","00800","00133","00719","00709","06110","09903","02579","02637","00568","00909","00780","00501","02687","00220","02676","00148","01429","00363","01765","01347","01833","02408","06821","09927","00168","02655","01211","01643","09999","09990","02583","00558","02276","06938","00259","00815","02489","00189","00019","02595","00650","02656","06979","00880","01458"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632267153","title":"每周股票复盘：凯莱英（002821）Q1营收增16.91%至18.02亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2632267153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632267153?lang=zh_cn&edition=full","pubTime":"2026-05-03 01:37","pubTimestamp":1777743429,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，凯莱英报收于125.56元，较上周的117.08元上涨7.24%。本周，凯莱英4月28日盘中最高价报129.49元。本周关注点业绩披露要点：凯莱英2026年一季度主营收入18.02亿元，同比上升16.91%。业绩披露要点凯莱英2026年一季报显示，一季度公司主营收入18.02亿元，同比上升16.91%；归母净利润3.04亿元，同比下降6.82%；扣非净利润2.72亿元，同比下降10.88%；负债率13.25%，投资收益2477.27万元，财务费用7814.91万元，毛利率43.02%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300000184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632158966","title":"格隆汇个股放量排行榜 | 5月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=2632158966","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632158966?lang=zh_cn&edition=full","pubTime":"2026-05-01 17:30","pubTimestamp":1777627804,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日天数智芯(09903)、上海实业控股(00363)、网易-S(09999)、永达汽车(03669)、永利澳门(01128)、中国铁建(01186)、中国信达(01359)、力量发展(01277)、中国光大银行(06818)、汽车街(02443)、中国白银集团(00815)、赛力斯(09927)、太古股份公司A(00019)、中信国际电讯(01883)、华星控股(08","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/01173056970876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["00800","00568","06110","00659","01347","01833","09927","00019","00259","09999","01765","00815","00981","00650","00133","02408","02516","00168","02276","02443","01211","01458","02687","00363","01643","00220","00178","00909","02676","00780","02595","06821","09990","00880","00189","02489","02655","00719","01429","06979","00501","00148","02637","02656","06938","00558","02583","09903","02579","00709"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2631469575","title":"凯莱英遭Schroders PLC减持25.89万股 每股作价约113.53港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2631469575","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631469575?lang=zh_cn&edition=full","pubTime":"2026-04-30 08:01","pubTimestamp":1777507260,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，4月28日，Schroders PLC减持凯莱英（06821）25.89万股，每股作价113.5268港元，总金额约为2939.21万港元。减持后最新持股数目为538.03万股，最新持股比例为19.33%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-04-30/doc-inhwfpqn7266535.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0132","LU1328615791.USD","EWH","BK0239","002821","06821","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631512887","title":"Norges Bank减持凯莱英(06821)18.49万股 每股作价约102.86港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2631512887","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631512887?lang=zh_cn&edition=full","pubTime":"2026-04-29 20:55","pubTimestamp":1777467357,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，4月27日，Norges Bank减持凯莱英(06821)18.49万股，每股作价102.8593港元，总金额约为1901.87万港元。减持后最新持股数目为405.66万股，最新持股比例为14.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002821","BK0132","EWH","LU1328615791.USD","BK1191","BK0239","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631551724","title":"交银国际：上调凯莱英(06821)目标价至136.6港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2631551724","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631551724?lang=zh_cn&edition=full","pubTime":"2026-04-29 10:31","pubTimestamp":1777429898,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，将凯莱英(06821,002821.SZ)H股目标价调高至136.6港元，A 股为159.2元人民币，维持“买入”的投资评级。基于首财季的超预期业绩表现，交银国际上调凯莱英2026-28年经调整净利润预测2-14%。该行指，尽管面临汇率波动和小份子业务高基数的影响，该公司在2026年首财季录得强劲且超预期的利润增长，反映出新兴业务订单需求的持续高涨和经营效率的提升。公司在高景气度赛道的后期订单规模扩大和前瞻性投入，可望带来较强的长期高增长确定性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002821","06821","EWH"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.asymchem.com","stockEarnings":[{"period":"1week","weight":0.0243},{"period":"1month","weight":0.0583},{"period":"3month","weight":0.2406},{"period":"6month","weight":0.3009},{"period":"1year","weight":0.5234},{"period":"ytd","weight":0.3904}],"compareEarnings":[{"period":"1week","weight":-0.038},{"period":"1month","weight":-0.0416},{"period":"3month","weight":-0.0389},{"period":"6month","weight":0.0066},{"period":"1year","weight":0.0654},{"period":"ytd","weight":-0.0095}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"凯莱英医药集团（天津）股份有限公司是一家主要从事提供医药外包一站式综合服务的中国公司。该公司的业务包括小分子药物定制研发生产（CDMO）、化学大分子CDMO、临床研究服务、制剂CDMO、生物大分子CDMO、技术输出和合成生物技术。该公司的产品类别涵盖多肽、寡核苷酸、单克隆抗体、抗体偶联药物和信使RNA等。该公司主要在国内外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.058446},{"month":2,"riseRate":0.4,"avgChangeRate":0.006896},{"month":3,"riseRate":0.4,"avgChangeRate":0.004398},{"month":4,"riseRate":0.6,"avgChangeRate":-0.036175},{"month":5,"riseRate":0.4,"avgChangeRate":0.020091},{"month":6,"riseRate":0.5,"avgChangeRate":0.01751},{"month":7,"riseRate":0.5,"avgChangeRate":0.064856},{"month":8,"riseRate":0.25,"avgChangeRate":-0.064097},{"month":9,"riseRate":0.75,"avgChangeRate":0.16322},{"month":10,"riseRate":0,"avgChangeRate":-0.125554},{"month":11,"riseRate":0.5,"avgChangeRate":0.010602},{"month":12,"riseRate":0.25,"avgChangeRate":-0.010177}],"exchange":"SEHK","name":"凯莱英","nameEN":"ASYMCHEM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,06821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}